Remove 2025 Remove Biosimilars Remove Inpatient
article thumbnail

CMS Issues Sweeping End-Of Year Rule on Medicare Advantage and Medicare Part D

Putting Patients First Blog

CMS is proposing setting a 20% coinsurance/equivalent copayment limit for behavioral health services, eliminating cost-sharing for opioid treatment program services, and capping inpatient psychiatric service cost sharing to 100% of Medicare Fee-For-Services levels. Comment Submission Comments on the proposed rule are due January 27, 2025.

article thumbnail

FDA Would Like to Join You in the Sandbox When Developing AI Enabled Devices

FDA Law Blog: Biosimilars

inpatient hospital, out-patient clinic), date range for the data, and location of the data collection sites (e.g., Both guidance documents recommend data management practices for collecting data for use in developing, tuning, and testing an artificial intelligence model and making changes to said model. data acquisition device).